FSUE NPO Microgen

Facts and figures

8

manufacturing sites

5229

specialists

11

mlrd roubles – total revenue of Microgen in 2020

40 ^%

the Company provides for country's needs in vaccines and toxoids

1

the exclusive producer of therapeutic bacteriophages

661

mln roubles – investments for development and production of the products in 2020

News

04.06.2021

New productions to be created at Microgen

01.06.2021

Relatox® entered the Uzbek market

20.05.2021

Microgen increases the export of pharmaceuticals to Uzbekistan

26.04.2021

NPO Microgen and National Association of the Specialists in Infections Control agreed to pool efforts in vaccination popularization area

15.04.2021

Perm subsidiary of NPO Microgen to expand the production of vaccines and blood products

09.02.2021

Microgen obtained registration for the new vaccine

23.12.2020

Microgen launched a mobile application about vaccines

07.12.2020

Relatox won the prestigious Beauty Award ′′Crystal Lotus”

02.12.2020

Evgeny Stavnichy was appointed Director of NPO Microgen Ufa subsidiary.

06.08.2020

Microgen to start the production of new allergy drugs

20.07.2020

Microgen started shipping its “three in one” combined vaccine against measles, rubella and mumps

28.05.2020

Perm subsidiary of NPO Microgen finished modernization of vaccine production department

25.03.2020

Bacteriophage products were included into the European Position Paper on Rhinosinusitis and Nasal Polyps treatment

27.02.2020

Bacteriophage products have been included into clinical recommendations for urology

06.02.2020

Microgen opened Biological Resource Center for bacteriophages study

29.01.2020

Relatox in dentistry: options of use

02.12.2019

NPO Microgen won an award for new vaccine creation

18.11.2019

New vaccine will protect from three infections by one injection

24.10.2019

Relatox® will extend the age of application in children with infantile cerebral paralysis (ICP)

18.10.2019

SPA Microgen and State Budgetary Healthcare Institution of the Moscow Region Moscow Regional Research and Clinical Institute named after M.F. Vladimirskiy ("MONIKI") start their co-operation in bacteriophages use development

All news

Products

We produce more than 350 medical products and we are
the biggest manufacturer of the immunobiological products in Russia.

Vaccines

Allergens

Anatoxins, toxins

Bacteriophages

Immunomodulators, interferons

Blood products

Sera

Culture media

Medical devices for diagnostics in vitro

Other medicines

Ufa

Tomsk

Stavropol

Nizhny Novgorod

Perm

Irkutsk

Moscow

Subsidiaries

9 manufacturing sites

Branch FSUC “SIC “Microgen” of MOH of Russia «Immunopreparat» in Ufa

Production of the products for diagnostic, prophylaxis and treatment of infectious, allergic, somatic diseases and for immunity enhancement

Branch FSUC “SIC “Microgen” of MOH of Russia “SIC “Virion” in Tomsk

Production of the vaccines, immunoglobulins, products for intestine microflora normalization, injection medical products

Branch FSUC “SIC “Microgen” of MOH of Russia “Allergen” in Stavropol

Production of the antitoxic sera, vaccines, end-products in ampoules, products against disbacteriosis, venereal diseases

Branch FSUC “SIC “Microgen” of MOH of Russia “Nizhny Novgorod Enterprise for Manufacture of Bacterial Products “ImBio” in Nizhny Novgorod

Production of the bacteriophages, probiotics, immunoglobulins, blood products

Branch FSUC “SIC “Microgen” of MOH of Russia “Perm SIC “Biomed” in Perm

Production of the immunobiological products and vaccines, recycling of human blood plasma

Branch FSUC “SIC “Microgen” of MOH of Russia «Irkutsk Enterprise for Manufacture of Bacterial Products» in Irkutsk

Production of live flu vaccine Ultravac

Branch FSUC “SIC “Microgen” of MOH of Russia “Moscow Subdivision for Manufacture of Bacterial Products” in Moscow

Vaccines production, especially against MMR provided for the Nacional Vaccination Schedule